Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stroke | 18 | 2018 | 315 | 3.080 |
Why?
|
Thrombectomy | 7 | 2018 | 31 | 1.940 |
Why?
|
Intracranial Aneurysm | 5 | 2016 | 34 | 1.840 |
Why?
|
Endovascular Procedures | 10 | 2018 | 37 | 1.770 |
Why?
|
Cerebral Angiography | 5 | 2016 | 33 | 1.580 |
Why?
|
Brain Ischemia | 9 | 2018 | 75 | 1.530 |
Why?
|
Embolization, Therapeutic | 5 | 2014 | 41 | 1.380 |
Why?
|
Intracranial Hemorrhages | 4 | 2017 | 14 | 1.180 |
Why?
|
Arteriovenous Fistula | 3 | 2016 | 10 | 1.090 |
Why?
|
Thrombolytic Therapy | 6 | 2014 | 58 | 1.060 |
Why?
|
Intracranial Arteriovenous Malformations | 2 | 2016 | 8 | 1.040 |
Why?
|
Aneurysm, Ruptured | 2 | 2016 | 16 | 1.020 |
Why?
|
Arterial Occlusive Diseases | 4 | 2017 | 12 | 0.840 |
Why?
|
Radial Artery | 1 | 2021 | 11 | 0.790 |
Why?
|
Humans | 48 | 2021 | 31038 | 0.670 |
Why?
|
Cerebrovascular Disorders | 3 | 2015 | 149 | 0.610 |
Why?
|
Stents | 4 | 2018 | 86 | 0.600 |
Why?
|
Middle Aged | 24 | 2019 | 10223 | 0.590 |
Why?
|
Patient Transfer | 1 | 2017 | 21 | 0.570 |
Why?
|
Tomography, X-Ray Computed | 7 | 2021 | 817 | 0.560 |
Why?
|
Female | 29 | 2021 | 16985 | 0.550 |
Why?
|
Informed Consent | 1 | 2015 | 22 | 0.500 |
Why?
|
Neurosurgery | 2 | 2015 | 49 | 0.500 |
Why?
|
Periodicals as Topic | 2 | 2015 | 42 | 0.500 |
Why?
|
Aged | 22 | 2019 | 10065 | 0.490 |
Why?
|
Self-Help Groups | 1 | 2014 | 5 | 0.490 |
Why?
|
Adult | 18 | 2021 | 8944 | 0.490 |
Why?
|
Mandible | 2 | 2018 | 16 | 0.490 |
Why?
|
Retrospective Studies | 15 | 2019 | 3663 | 0.480 |
Why?
|
Male | 28 | 2019 | 16479 | 0.460 |
Why?
|
Social Media | 1 | 2014 | 33 | 0.460 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2014 | 68 | 0.460 |
Why?
|
Vascular Access Devices | 1 | 2013 | 5 | 0.460 |
Why?
|
Maxilla | 1 | 2013 | 2 | 0.450 |
Why?
|
Cerebral Arteries | 1 | 2013 | 32 | 0.450 |
Why?
|
Aged, 80 and over | 14 | 2018 | 5195 | 0.410 |
Why?
|
Checklist | 1 | 2011 | 38 | 0.390 |
Why?
|
Bone Transplantation | 1 | 2013 | 234 | 0.380 |
Why?
|
Intraoperative Complications | 1 | 2011 | 75 | 0.380 |
Why?
|
Tibia | 1 | 2013 | 274 | 0.380 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2010 | 4 | 0.380 |
Why?
|
Estrogen Replacement Therapy | 1 | 2010 | 21 | 0.370 |
Why?
|
Adolescent | 8 | 2018 | 2400 | 0.360 |
Why?
|
Device Removal | 1 | 2010 | 91 | 0.350 |
Why?
|
Predictive Value of Tests | 3 | 2017 | 555 | 0.340 |
Why?
|
Polycystic Kidney Diseases | 1 | 2009 | 4 | 0.330 |
Why?
|
Connective Tissue Diseases | 1 | 2009 | 9 | 0.330 |
Why?
|
Migraine Disorders | 1 | 2009 | 14 | 0.330 |
Why?
|
Communicable Diseases | 1 | 2009 | 24 | 0.330 |
Why?
|
Follow-Up Studies | 8 | 2018 | 1936 | 0.320 |
Why?
|
Heart Defects, Congenital | 1 | 2009 | 31 | 0.320 |
Why?
|
Neuroradiography | 1 | 2008 | 3 | 0.310 |
Why?
|
Radiology, Interventional | 1 | 2008 | 6 | 0.310 |
Why?
|
Vascular Surgical Procedures | 1 | 2008 | 28 | 0.300 |
Why?
|
Education, Medical, Graduate | 1 | 2008 | 88 | 0.280 |
Why?
|
Neurology | 1 | 2008 | 79 | 0.280 |
Why?
|
Prognosis | 5 | 2018 | 923 | 0.280 |
Why?
|
Inflammation | 1 | 2009 | 361 | 0.280 |
Why?
|
Young Adult | 7 | 2018 | 2057 | 0.260 |
Why?
|
Tissue Plasminogen Activator | 4 | 2015 | 43 | 0.260 |
Why?
|
Magnetic Resonance Angiography | 3 | 2016 | 35 | 0.260 |
Why?
|
Adenoviridae | 1 | 2005 | 19 | 0.260 |
Why?
|
Morbidity | 2 | 2016 | 65 | 0.260 |
Why?
|
Nanostructures | 1 | 2005 | 13 | 0.260 |
Why?
|
False Positive Reactions | 2 | 2017 | 36 | 0.260 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2018 | 230 | 0.250 |
Why?
|
Genetic Vectors | 1 | 2005 | 63 | 0.250 |
Why?
|
Blood-Brain Barrier | 1 | 2005 | 44 | 0.250 |
Why?
|
Genetic Therapy | 1 | 2005 | 93 | 0.240 |
Why?
|
Treatment Outcome | 9 | 2018 | 3807 | 0.240 |
Why?
|
Aorta, Thoracic | 1 | 2004 | 11 | 0.230 |
Why?
|
Wounds, Nonpenetrating | 1 | 2004 | 12 | 0.230 |
Why?
|
Coronary Angiography | 2 | 2021 | 99 | 0.210 |
Why?
|
Physical Exertion | 1 | 2002 | 9 | 0.210 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 344 | 0.210 |
Why?
|
Kidney Neoplasms | 2 | 2013 | 69 | 0.210 |
Why?
|
Catheter Ablation | 2 | 2013 | 107 | 0.190 |
Why?
|
Child | 4 | 2015 | 1428 | 0.190 |
Why?
|
Lung Diseases | 1 | 2021 | 50 | 0.180 |
Why?
|
Drug-Eluting Stents | 1 | 2019 | 11 | 0.170 |
Why?
|
Angiography, Digital Subtraction | 2 | 2016 | 5 | 0.160 |
Why?
|
Percutaneous Coronary Intervention | 1 | 2019 | 24 | 0.160 |
Why?
|
Clinical Trials as Topic | 3 | 2015 | 331 | 0.160 |
Why?
|
Pelvic Neoplasms | 1 | 2018 | 5 | 0.160 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2018 | 10 | 0.160 |
Why?
|
Embolectomy | 2 | 2015 | 5 | 0.160 |
Why?
|
Intraoperative Care | 1 | 2018 | 46 | 0.160 |
Why?
|
Fibrinolytic Agents | 3 | 2017 | 63 | 0.160 |
Why?
|
Cheek | 1 | 2018 | 1 | 0.160 |
Why?
|
Prognathism | 1 | 2018 | 2 | 0.160 |
Why?
|
Radiotherapy, Intensity-Modulated | 2 | 2018 | 34 | 0.160 |
Why?
|
Taiwan | 2 | 2019 | 7 | 0.160 |
Why?
|
Renal Dialysis | 1 | 2019 | 111 | 0.150 |
Why?
|
Myocardial Infarction | 1 | 2019 | 179 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2016 | 360 | 0.150 |
Why?
|
Societies, Medical | 2 | 2015 | 191 | 0.140 |
Why?
|
Evidence-Based Medicine | 2 | 2015 | 216 | 0.140 |
Why?
|
Rupture, Spontaneous | 1 | 2016 | 7 | 0.130 |
Why?
|
Computed Tomography Angiography | 1 | 2016 | 35 | 0.130 |
Why?
|
Subdural Effusion | 1 | 2015 | 7 | 0.130 |
Why?
|
Hematoma, Subdural, Acute | 1 | 2015 | 8 | 0.130 |
Why?
|
Neurologic Examination | 1 | 2016 | 138 | 0.130 |
Why?
|
Research Report | 1 | 2015 | 7 | 0.130 |
Why?
|
Extracellular Fluid | 1 | 2014 | 3 | 0.120 |
Why?
|
Research Personnel | 1 | 2015 | 21 | 0.120 |
Why?
|
Writing | 1 | 2015 | 22 | 0.120 |
Why?
|
Cerebrospinal Fluid | 1 | 2014 | 18 | 0.120 |
Why?
|
Decision Support Techniques | 1 | 2015 | 52 | 0.120 |
Why?
|
Posterior Cerebral Artery | 1 | 2014 | 2 | 0.120 |
Why?
|
Radiosurgery | 1 | 2015 | 38 | 0.120 |
Why?
|
Animals | 5 | 2014 | 4713 | 0.120 |
Why?
|
Medulloblastoma | 1 | 2014 | 6 | 0.120 |
Why?
|
Radiation Tolerance | 1 | 2014 | 7 | 0.120 |
Why?
|
Cerebellar Neoplasms | 1 | 2014 | 6 | 0.120 |
Why?
|
Aneurysm | 1 | 2014 | 12 | 0.120 |
Why?
|
Hearing Loss | 1 | 2014 | 13 | 0.120 |
Why?
|
Patient Outcome Assessment | 1 | 2014 | 44 | 0.120 |
Why?
|
Hearing | 1 | 2014 | 23 | 0.120 |
Why?
|
Brain Injuries | 1 | 2014 | 47 | 0.120 |
Why?
|
Databases, Factual | 1 | 2016 | 353 | 0.120 |
Why?
|
Biomedical Research | 1 | 2014 | 80 | 0.110 |
Why?
|
False Negative Reactions | 1 | 2013 | 15 | 0.110 |
Why?
|
Brain Neoplasms | 1 | 2015 | 133 | 0.110 |
Why?
|
Neurofibrillary Tangles | 1 | 2014 | 199 | 0.110 |
Why?
|
Tissue and Organ Harvesting | 1 | 2013 | 18 | 0.110 |
Why?
|
Psychometrics | 1 | 2014 | 270 | 0.110 |
Why?
|
tau Proteins | 1 | 2014 | 230 | 0.110 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2013 | 9 | 0.110 |
Why?
|
Neurosurgical Procedures | 1 | 2015 | 162 | 0.110 |
Why?
|
Tertiary Care Centers | 1 | 2013 | 74 | 0.110 |
Why?
|
Patient Selection | 2 | 2015 | 246 | 0.110 |
Why?
|
Hospitalization | 1 | 2015 | 336 | 0.100 |
Why?
|
Pilot Projects | 1 | 2013 | 427 | 0.100 |
Why?
|
Cost-Benefit Analysis | 1 | 2012 | 149 | 0.100 |
Why?
|
Angioplasty | 2 | 2010 | 5 | 0.100 |
Why?
|
Radiotherapy Dosage | 3 | 2018 | 119 | 0.100 |
Why?
|
Neoplasms | 1 | 2015 | 261 | 0.100 |
Why?
|
Ductus Arteriosus | 1 | 2011 | 1 | 0.100 |
Why?
|
Fetal Diseases | 1 | 2011 | 7 | 0.100 |
Why?
|
Heart Aneurysm | 1 | 2011 | 6 | 0.100 |
Why?
|
Kidney | 1 | 2013 | 181 | 0.100 |
Why?
|
Thromboembolism | 1 | 2011 | 20 | 0.100 |
Why?
|
Injections, Intra-Arterial | 1 | 2011 | 8 | 0.100 |
Why?
|
Foramen Ovale, Patent | 1 | 2011 | 15 | 0.100 |
Why?
|
Transportation of Patients | 1 | 2011 | 6 | 0.100 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2011 | 16 | 0.090 |
Why?
|
Suction | 1 | 2011 | 48 | 0.090 |
Why?
|
Cerebrovascular Circulation | 1 | 2011 | 44 | 0.090 |
Why?
|
Antifibrinolytic Agents | 1 | 2011 | 21 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 149 | 0.090 |
Why?
|
Assisted Circulation | 1 | 2010 | 4 | 0.090 |
Why?
|
Chicago | 1 | 2013 | 938 | 0.090 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 999 | 0.090 |
Why?
|
Hypothermia, Induced | 1 | 2010 | 22 | 0.090 |
Why?
|
Angioplasty, Balloon | 1 | 2009 | 19 | 0.090 |
Why?
|
Infant, Newborn | 3 | 2021 | 635 | 0.090 |
Why?
|
Logistic Models | 1 | 2010 | 410 | 0.090 |
Why?
|
Radiography | 1 | 2011 | 695 | 0.080 |
Why?
|
Vasoconstriction | 1 | 2009 | 25 | 0.080 |
Why?
|
Surveys and Questionnaires | 1 | 2014 | 1210 | 0.080 |
Why?
|
Risk Factors | 1 | 2016 | 2581 | 0.080 |
Why?
|
Case-Control Studies | 1 | 2010 | 661 | 0.080 |
Why?
|
Hepatocyte Nuclear Factor 6 | 1 | 2008 | 1 | 0.080 |
Why?
|
Human Growth Hormone | 1 | 2008 | 3 | 0.080 |
Why?
|
Cholestasis, Extrahepatic | 1 | 2008 | 3 | 0.080 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2008 | 7 | 0.080 |
Why?
|
Intracranial Thrombosis | 1 | 2008 | 6 | 0.080 |
Why?
|
Infant | 2 | 2014 | 571 | 0.080 |
Why?
|
Prospective Studies | 1 | 2013 | 1896 | 0.080 |
Why?
|
Medicine | 1 | 2008 | 11 | 0.080 |
Why?
|
Age Factors | 1 | 2010 | 872 | 0.080 |
Why?
|
Specialization | 1 | 2008 | 17 | 0.080 |
Why?
|
Child, Preschool | 2 | 2014 | 686 | 0.080 |
Why?
|
Teaching | 1 | 2008 | 62 | 0.070 |
Why?
|
Education, Medical | 1 | 2008 | 49 | 0.070 |
Why?
|
Recovery of Function | 1 | 2008 | 298 | 0.070 |
Why?
|
Survival Rate | 2 | 2018 | 407 | 0.070 |
Why?
|
Convection | 1 | 2005 | 1 | 0.060 |
Why?
|
Osmosis | 1 | 2005 | 6 | 0.060 |
Why?
|
Structure-Activity Relationship | 1 | 2005 | 43 | 0.060 |
Why?
|
Aortography | 1 | 2004 | 10 | 0.060 |
Why?
|
Trauma Centers | 1 | 2004 | 7 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 1 | 2005 | 467 | 0.060 |
Why?
|
Kidney Function Tests | 2 | 2013 | 24 | 0.050 |
Why?
|
Rats | 1 | 2005 | 870 | 0.050 |
Why?
|
Glomerular Filtration Rate | 2 | 2013 | 61 | 0.050 |
Why?
|
Lactic Acid | 1 | 2002 | 17 | 0.050 |
Why?
|
Publication Bias | 1 | 2002 | 8 | 0.050 |
Why?
|
Oxygen Consumption | 1 | 2002 | 51 | 0.050 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2002 | 4 | 0.050 |
Why?
|
Physical Fitness | 1 | 2002 | 60 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2002 | 326 | 0.050 |
Why?
|
Angiography | 1 | 2002 | 44 | 0.050 |
Why?
|
Heart Rate | 1 | 2002 | 161 | 0.050 |
Why?
|
Venous Thrombosis | 1 | 2002 | 45 | 0.050 |
Why?
|
Spinal Cord Diseases | 1 | 2002 | 53 | 0.050 |
Why?
|
Lung | 1 | 2021 | 173 | 0.040 |
Why?
|
Pregnancy | 1 | 2021 | 403 | 0.040 |
Why?
|
Malocclusion, Angle Class III | 1 | 2018 | 1 | 0.040 |
Why?
|
Osteotomy, Sagittal Split Ramus | 1 | 2018 | 1 | 0.040 |
Why?
|
Cephalometry | 1 | 2018 | 4 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2018 | 120 | 0.040 |
Why?
|
Bayes Theorem | 1 | 2017 | 41 | 0.040 |
Why?
|
Time-to-Treatment | 1 | 2017 | 37 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 160 | 0.040 |
Why?
|
Mice | 2 | 2014 | 1681 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 386 | 0.030 |
Why?
|
Osteotomy | 1 | 2018 | 171 | 0.030 |
Why?
|
Cerebral Infarction | 1 | 2017 | 164 | 0.030 |
Why?
|
Reperfusion | 1 | 2015 | 7 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2017 | 333 | 0.030 |
Why?
|
Brain | 1 | 2005 | 1800 | 0.030 |
Why?
|
Time Factors | 2 | 2011 | 1678 | 0.030 |
Why?
|
Aquaporin 4 | 1 | 2014 | 6 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2014 | 76 | 0.030 |
Why?
|
Speech Disorders | 1 | 2014 | 11 | 0.030 |
Why?
|
Nerve Degeneration | 1 | 2014 | 54 | 0.030 |
Why?
|
Forecasting | 1 | 2014 | 115 | 0.030 |
Why?
|
Disease Management | 1 | 2015 | 126 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 54 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2015 | 344 | 0.030 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2014 | 71 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2014 | 323 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2015 | 399 | 0.030 |
Why?
|
Iohexol | 1 | 2013 | 5 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 464 | 0.030 |
Why?
|
Radiography, Interventional | 1 | 2013 | 30 | 0.030 |
Why?
|
Biopsy | 1 | 2013 | 249 | 0.030 |
Why?
|
Contrast Media | 1 | 2013 | 136 | 0.030 |
Why?
|
Comorbidity | 1 | 2013 | 507 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2011 | 105 | 0.020 |
Why?
|
Middle Cerebral Artery | 1 | 2009 | 9 | 0.020 |
Why?
|
Registries | 1 | 2011 | 203 | 0.020 |
Why?
|
Carotid Arteries | 1 | 2009 | 53 | 0.020 |
Why?
|
Ultrasonography | 1 | 2011 | 271 | 0.020 |
Why?
|
Acute Disease | 1 | 2009 | 232 | 0.020 |
Why?
|
United States | 1 | 2015 | 2376 | 0.020 |
Why?
|
Cholesterol 7-alpha-Hydroxylase | 1 | 2008 | 1 | 0.020 |
Why?
|
Cyclin D | 1 | 2008 | 1 | 0.020 |
Why?
|
Cyclins | 1 | 2008 | 6 | 0.020 |
Why?
|
Organic Anion Transporters, Sodium-Dependent | 1 | 2008 | 4 | 0.020 |
Why?
|
Symporters | 1 | 2008 | 5 | 0.020 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2008 | 21 | 0.020 |
Why?
|
Hepatocytes | 1 | 2008 | 10 | 0.020 |
Why?
|
Ligation | 1 | 2008 | 33 | 0.020 |
Why?
|
Liver Regeneration | 1 | 2008 | 23 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2008 | 107 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2008 | 256 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2008 | 204 | 0.020 |
Why?
|
Up-Regulation | 1 | 2008 | 177 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2013 | 996 | 0.020 |
Why?
|
Mesenteric Veins | 1 | 2002 | 2 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 2002 | 15 | 0.010 |
Why?
|
Myelography | 1 | 2002 | 10 | 0.010 |
Why?
|
Cohort Studies | 1 | 2008 | 2040 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 2002 | 16 | 0.010 |
Why?
|
Aortic Aneurysm | 1 | 2002 | 16 | 0.010 |
Why?
|
Obesity, Morbid | 1 | 2002 | 98 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2002 | 1320 | 0.010 |
Why?
|